Prnews

EVERISE ANNOUNCES SUCCESSFUL CLOSURE OF INVESTMENT BY WARBURG PINCUS, JOINING BROOKFIELD FOR THE NEXT PHASE OF GROWTH

December 21, 2023 01:16 PM AEDT| By Cision

NEW YORK, SINGAPORE and MUMBAI, Dec. 21, 2023 /PRNewswire/ -- Everise, a leading global healthcare services outsourcing company, announced today the successful completion of the company's...

Highlights from the 8th Customer Experience Summit by CCAM

December 21, 2023 01:00 PM AEDT| By Cision

Content was King but AI rules CX Summit 2023 In Kuala Lumpur KUALA LUMPUR, Malaysia, Dec. 21, 2023 /PRNewswire/ -- The 8th Customer Experience Summit, hosted by the Contact Centre Association of...

ADA Shines Bright at the Prestigious Effie Awards, Securing Gold, Silver, and Bronze Accolades for Exceptional Excellence

December 21, 2023 01:00 PM AEDT| By Cision

COLOMBO, Sri Lanka, Dec. 21, 2023 /PRNewswire/ -- ADA, Asia's largest independent Data and Digital Transformation company, proudly announced its great wins at the prestigious Effie Awards...

Tribesigns Partners with One Tree Planted for Environmental Initiatives

December 21, 2023 01:00 PM AEDT| By Cision

LOS ANGELES, Dec. 21, 2023 /PRNewswire/ -- Tribesigns, a globally acclaimed online furniture brand, has announced a partnership with One Tree Planted, a non-profit organization that focuses on...

ENA Building Momentum Globally in Support of Emergency Nurses

December 21, 2023 12:00 PM AEDT| By Cision

Partnerships help gold standard TNCC and ENPC courses reach more international ED nurses SCHAUMBURG, Ill., Dec. 21, 2023 /PRNewswire/ -- After a year dedicated to expanding its international co...

Explore AsiaRF's Wireless Innovations at CES 2024, Las Vegas: Tech Excellence Unveiled.

December 21, 2023 11:53 AM AEDT| By Cision

TAIPEI, Dec. 21, 2023 /PRNewswire/ -- AsiaRF, a global leader in wireless connectivity, is thrilled to announce its participation in CES 2024, the world's premier tech event, held in Las Vegas from Ja...

BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial

December 21, 2023 11:26 AM AEDT| By Cision

WUXI, China, Dec. 21, 2023 /PRNewswire/ -- BioCity Biopharma today announced dosing of the first patient in a Phase Ib/II clinical trial of its anti-TIM-3 monoclonal antibody (mAb) BC3402 in combinati...

DEEPX Making High-Performance, Low-Power AI Servers A Reality with DX-H1 Launch at CES 2024

December 21, 2023 11:00 AM AEDT| By Cision

The award-winning AI booster achieves over 10 times power-to-performance efficiency compared to GPUs LAS VEGAS, Dec. 21, 2023 /PRNewswire/ -- DEEPX (CEO, Lokwon Kim), an original AI semiconductor tech...

MONTECH Unveils the Versatile Mid-Tower with Curved Elegance - The KING 95

December 21, 2023 11:00 AM AEDT| By Cision

Redefined Aesthetics & Elevated Performance Beyond Flat Screens: The Allure of Curved Glass Experiences Hardware Harmony with Dual Chamber: Exceptional Compatibility Included Premium Front Mesh P...

Hyundai Motor to Reveal Vision for Hydrogen and Software Beyond Mobility at CES 2024

December 21, 2023 10:30 AM AEDT| By Cision

Hyundai will reveal its future blueprint for hydrogen energy as well as software and AI at CES 2024 Hyundai to foster human-centered innovations beyond mobility to 'Ease every way' Media Day to...

BLACKHAWK NETWORK (BHN) TRAILBLAZER AWARDED FOR PAYMENTS INNOVATION

December 21, 2023 09:37 AM AEDT| By Cision

SINGAPORE, Dec. 21, 2023 /PRNewswire/ -- Blackhawk Network (BHN) Singapore-based Regional Vice President, Business Development, Judy Li has been recognised for her outstanding contribution to the glob...

YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting

December 21, 2023 08:30 AM AEDT| By Cision

GAITHERSBURG, Md., Dec. 21, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to disco...

/DISREGARD RELEASE: YS Biopharma/

December 21, 2023 08:15 AM AEDT| By Cision

We are advised by YS Biopharma Co., Ltd. (NASDAQ:YS) that journalists and other readers should disregard the news release, "YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on Decembe...

Omnicom Media Group Ends 2023 Ranked #1 for Net New Business for the Second Consecutive Year, Earns 97% Retention Rate Among Existing Clients

December 21, 2023 08:00 AM AEDT| By Cision

OMG agencies OMD, Hearts & Science and PHD wrap the year achieving historic trifecta atop the agency ranking NEW YORK, Dec. 20, 2023 /PRNewswire/ -- Omnicom Media Group (OMG), the medi...

REP Fitness Expands Global Presence with TheRack.Co in the Philippines

December 21, 2023 07:42 AM AEDT| By Cision

The TheRack.Co to Exclusively Carry the REP Line DENVER, Dec. 21, 2023 /PRNewswire/ -- REP Fitness, a leading name in high-quality fitness equipment, proudly announces a strategic partnership w...

CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors

December 21, 2023 04:00 AM AEDT| By Cision

HANGZHOU, China, Dec. 21, 2023 /PRNewswire/ -- Recently, a CAR-macrophage therapy product (CAR-M) SY001 from CellOrigin Biotechnology (Hangzhou) Co., Ltd. was dosed to the first patient in a hosp...